|
시장보고서
상품코드
2078918
신경 이미징 시장 : 기술별, 용도별, 최종사용자별, 지역별Neuroimaging Market, By Technology, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
신경 이미징 시장은 2026년에 449억 달러로 추정되며, 2033년까지 684억 1,000만 달러에 이를 전망입니다. 또한, 2026-2033년 CAGR 6.2%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 449억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.20% | 2033년 시장 규모 예측 : | 684억 1,000만 달러 |
신경 이미징은 뇌의 구조와 기능을 시각화할 수 있는 의료 영상 진단의 한 분야입니다. 다양한 질환과 장애의 근저에 있는 신경학적 과정 및 이상에 대해 귀중한 인사이트를 제공합니다. 이 기술은 신경과학 분야에 혁명을 일으켰으며, 인간의 뇌를 이해하는 데 크게 기여해 왔습니다.
시장 역학:
신경 이미징 시장은 몇 가지 요인에 의해 주도되고 있습니다. 신경 질환의 유병률이 증가함에 따라 정확한 진단 도구에 대한 수요가 높아지고 있으며, 그 결과 신경 이미징 기술의 도입이 확대되고 있습니다. 또한, 자기공명영상법(MRI), 양전자방출단층촬영법(PET), 컴퓨터단층촬영법(CT) 등의 영상 진단 기술의 발전으로 뇌 영상의 해상도와 정확도가 크게 향상되었습니다.
그러나 이 시장에는 몇 가지 제약 사항도 존재합니다. 신경 이미징 장치의 높은 비용과 이에 따른 유지보수 및 운영 비용이, 특히 개발도상국에서 그 이용에 걸림돌이 되고 있습니다. 또한, CT 촬영 시 발생하는 전리 방사선 피폭 등 특정 영상 진단법과 관련된 안전성 문제도 시장 성장에 있어 과제로 대두되고 있습니다.
그럼에도 불구하고, 신경 이미징 시장에는 몇 가지 기회가 존재합니다. 기능적 자기공명영상법(fMRI)이나 확산 텐서 영상법(DTI)과 같은 첨단 영상 진단 기술 개발을 위한 연구 개발(R&D) 활동에 대한 투자가 증가하고 있으며, 이것이 시장 성장을 견인할 것으로 예측됩니다. 맞춤형 의료에 대한 관심이 높아지고 있는 점과 신경 이미징에 인공지능(AI)을 접목하는 것은 시장 확대를 위한 새로운 길을 열어주고 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 신경 이미징 시장의 주요 기업 프로파일을 작성하고 있습니다. 본 조사에서 다루고 있는 주요 기업으로는 General Electric Company, Siemens Healthineers AG, and Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, and Trifoil Imaging 등이 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 각 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 이 신경 이미징 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 신경 이미징 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 신경 이미징 시장 : 기술별, 2021년-2033년
제5장 신경 이미징 시장 : 용도별, 2021년-2033년
제6장 신경 이미징 시장 : 최종사용자별, 2021년-2033년
제7장 신경 이미징 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.07.10Neuroimaging Market is estimated to be valued at USD 44.90 Bn in 2026 and is expected to reach USD 68.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 44.90 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.20% | 2033 Value Projection: | USD 68.41 Bn |
Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underline various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.
Market Dynamics:
The neuroimaging market is driven by several factors. Growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, thus leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.
However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.
Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development (R&D) activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, and Trifoil Imaging..
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the neuroimaging market
Detailed Segmentation:
- Neuroimaging Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Functional Magnetic Resonance Imaging (fMRI)
- Diffusion Tensor Imaging (DTI)
- Magnetoencephalography (MEG)
- Electroencephalography (EEG)
- Others
- Neuroimaging Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Neurological Disorders
- Alzheimers Disease
- Parkinsons Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Brain Tumors
- Others
- Neuroimaging Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Centers
- Research Institutes
- Ambulatory Surgical Centers
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in Neuroimaging Market
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- NeuroVive Pharmaceutical AG
- Brainlab AG
- Akili Interactive Labs Inc.
- Brainomix Ltd.
- Imaging Science International
- Mevis Medical Solutions
- NeuroVista
- Neusoft Medical Systems
- Positron Corporation
- Shimadzu Corporation
- Trifoil Imaging
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Market Restraints
- Market Opportunities
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTERs Analysis
- Mergers, Acquisitions, and Collaborations
4. Neuroimaging Market, By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Functional Magnetic Resonance Imaging (fMRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diffusion Tensor Imaging (DTI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Magnetoencephalography (MEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Electroencephalography (EEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Neuroimaging Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Alzheimers Disease
- Parkinsons Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Brain Tumors
- Others
6. Neuroimaging Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Neuroimaging Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Company Profile
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Toshiba Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Esaote SpA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroLogica Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroVive Pharmaceutical AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Brainlab AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Akili Interactive Labs Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Brainomix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Imaging Science International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mevis Medical Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroVista
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Neusoft Medical Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Positron Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shimadzu Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Trifoil Imaging.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Analyst Views
9. Section
- References
- Research Methodology
- About us
